Study questions accuracy of genetic test for opioid use disorder

Opioid misuse and specifically opioid use disorder (OUD), continues to represent a significant U.S. public health threat, with more than 6 million Americans aged 12 and older meeting the criteria for OUD in 2022.

Bristol Myers pushes back ‘peak’ for new product sales, citing challenging uptake for Sotyktu, Camzyos

Bristol Myers Squibb is facing several questions about its mid-term future after it delayed sales projections for its new product portfolio, which includes Reblozyl and

October 27, 2023

Why CG Oncology will be the first test of 2024’s IPO waters

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, everyone. Damian

January 4, 2024

New AI system achieves 98.5% accuracy in autism diagnosis

A newly developed artificial intelligence (AI) system that analyzes specialized MRIs of the brain accurately diagnosed children between the ages of 24 and 48 months

November 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.